One of the greatest sources of untapped revenue lies in oncology, where an unmet need for cancer prevention also promises to drive innovation...
CancerIQ data shows 2 in 5 patients who undergo comprehensive cancer risk assessment and genetic testing require a change in medical management.
What separates the genetics programs that succeed from those that don’t? Learn how your health system can address this gap by working with CancerIQ...
In a recent webinar hosted by the Association of Cancer Executives, CancerIQ’s Senior Vice President of Commercial Strategy, John Hansel, discussed...
Genomics has an established benefit in precision cancer care for patients and providers alike – but its positive financial impact on your health...
There are many clear benefits to building a genetics program focused on identifying and treating patients with a high risk of a cancer diagnosis.
Community centers lose revenue potential from patient leakage, up to $650,000, on average, per patient. But what if there were a way to plug those...
CEO Feyi Olopade looks back on a great 2019 - and offers words for an even better 2020.
Learn how primary care physicians leverage technology to meet the USPSTF BRCA recommendations to provide risk assessment to more women in routine...
Innovative solutions that make breast cancer risk assessment and genetics more accessible are helping systems address the Triple Aim.